Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone as Add-on to Riluzole in ALS
NCT00635960Phase 2Completed
- Sponsor
- University of Naples Federico II
- Start
- Mar 2007
- Primary completion
- Jul 2009
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of somatropin in amyotrophic lateral sclerosis (ALS), sponsored by University of Naples Federico II. Started Mar 2007; status: completed.
02
Drugs
somatropin
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT00635960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00635960.